Clinical TrialDepressive DisordersPlaceboPlaceboCompleted
Psyrreal VR Psychedelic Replication Feasibility Study — Estonia 2021
TBD
Target Enrollment
14 participants
Study Type
Phase NA interventional
Design
Non-randomized
Detailed Description
TBD
Study Arms & Interventions
Control VR
placeboA 5-minute demonstrative VR experience in a small room with a balcony view onto a mountain range, used as a control condition for comparisons with EDI, PIQ, and MEQ30 measures.
Interventions
- Placebo• single dose• 1 doses total
5-minute demonstrative VR experience
Psyrreal VR
experimentalA 45-minute psychedelic-inspired virtual reality experience implementing various audiovisual and narrative phenomenological elements.
Interventions
- Placebo• single dose• 1 doses total
45-minute VR experience implemented on the second day of a 2-day intervention
Study Details
- StatusCompleted
- PhasePhase NA
- Typeinterventional
- DesignNon-randomized
- Target Enrollment14 participants
- TimelineStart: 2022-01-01End: 2022-01-01
- Compounds
- Topic
Locations
Estonia